Supplementary Material for: Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
Georges Nakhoul(Cleveland Clinic), Sankar D. Navaneethan(Baylor College of Medicine), Jesse D. Schold(Colorado School of Public Health), Hui-Ting Huang, Joseph V. Nally(Cleveland Clinic), Sagar Jolly(Cleveland Clinic), Susana Arrigain(Cleveland Clinic)
Cited by 0
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330
Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data
|Journal of the American Society of Nephrology|2019|209